Isoflavones linked to elevated risk of advanced prostate cancer in new study

494a57f9-eb9f-4200-8637-15b026652ce1articleimage.jpg

09 Nov 2017 --- An International Journal of Cancer study has linked the dietary intake of isoflavones to an elevated risk of advanced prostate cancer. Isoflavones are a type of phytoestrogen, a family of estrogen-like compounds found in plants and are found in soybeans, kudzu root and American groundnuts. The study notes that no statistically significant associations were observed between the intake of isoflavones and non-advanced prostate cancer in the study.

Much of the previous findings related to the compounds have been positive. Soy isoflavones have previously been linked to easing the symptoms of polycystic ovary syndrome with improvements being seen in areas including levels of insulin resistance. Soy isoflavones have also been found to offer protection against menopausal symptoms and coronary heart disease.

During a median follow up of 11.5 years for the International Journal of Cancer study, 2,598 cases of prostate cancer (including 287 advanced cases) were identified among 27,004 men in the intervention arm of the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Dietary intake was assessed with a food frequency questionnaire.

“Prostate cancer is a major cancer in Western countries, and its incidence rate has been remarkably increasing in Asian countries during the last several decades,” says senior author Dr. Jianjun Zhang, of the Indiana University Fairbanks School of Public Health. “Our study offers novel evidence that dietary intake of isoflavones has different effects on advanced and non-advanced prostate cancer.”

“This observation is important for understanding the etiology and prevention of prostate cancer but needs to be confirmed in more epidemiologic studies among populations with diverse dietary habits,” Zhang concludes.

RELATED ARTICLES
Homepicture

CJ CheilJedang to expand L-Arginine and L-Citrulline production in Indonesia

13 Apr 2018 8 --- CJ CheilJedang is making plans to build a ...

Homepicture

Clinical merger: Novartis acquires AveXis for US$8.7bn, expands in gene therapy

09 Apr 2018 Novartis has entered into an agreement and plan ...

Homepicture

GSK to take full ownership of Novartis stake in Consumer Healthcare Business for US$13bn

27 Mar 2018 GlaxoSmithKline (GSK) has reached an agreement ...

Homepicture

Probi signs agreement with pharma company Cilag on probiotic OTC product

23 Mar 2018 Probi has signed a long-term agreement with ...

Homepicture

Gelita develops controlled soft gelatin capsule fill release

12 Mar 2018 Gelita is offering manufacturers of soft gelatin ...